2017 / 01

Next Paper
DOI: 10.24075/brsmu.2017-01-04

ORIGINAL RESEARCH

Aminopyridine- and aminopyrimidine-based serine/threonine protein kinase inhibitors are drug candidates for treating drug-resistant tuberculosis

Maslov DA1, Bekker OB1, Alekseeva MG1, Kniazeva LM1, Mavletova DA1, Afanasyev II2, Vasilevich NI2, Danilenko VN
About authors

1 Laboratory of Bacterial Genetics, Department of Genetics and Biotechnology,
Vavilov Institute of General Genetics of RAS, Moscow, Russia

2 Novie Nauchnie Tekhnologii Ltd., Moscow, Russia

Correspondence should be addressed: Valery N. Danilenko
ul. Gubkina, d. 3, Moscow, Russia, 119991; ur.ggiv@direlav

About paper

Funding: this work was supported by the Ministry of Education and Science of the Russian Federation (Grant No. 14.576.21.0019 dated July 27, 2014; ID RFMEFI57614X0019).

Contribution of the authors to this work: Maslov DA — experiment planning, data collection, analysis and interpretation, drafting a manuscript; Bekker OB — experiment planning, data analysis and interpretation, drafting a manuscript; Alekseeva MG, Kniazeva LM, Mavletova DA — data collection, participation in drafting of a manuscript; Afanasyev II, Vasilevich NI — provision of compound under study, participation in drafting a manuscript; Danileno VN — experiment planning, data interpretation, participation in drafting of a manuscript.

Received: 2017-01-30 Accepted: 2017-02-11 Published online: 2017-03-13
|
No data available...